chr13-23279524-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000231.3(SGCG):c.505+46T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0257 in 1,590,500 control chromosomes in the GnomAD database, including 777 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 64 hom., cov: 32)
Exomes 𝑓: 0.026 ( 713 hom. )
Consequence
SGCG
NM_000231.3 intron
NM_000231.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.498
Genes affected
SGCG (HGNC:10809): (sarcoglycan gamma) This gene encodes gamma-sarcoglycan, one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin. The dystrophin-glycoprotein complex (DGC) spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Defects in the encoded protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 13-23279524-T-A is Benign according to our data. Variant chr13-23279524-T-A is described in ClinVar as [Benign]. Clinvar id is 255602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-23279524-T-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0735 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0218 AC: 3313AN: 152006Hom.: 64 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3313
AN:
152006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0320 AC: 7865AN: 245708 AF XY: 0.0320 show subpopulations
GnomAD2 exomes
AF:
AC:
7865
AN:
245708
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0261 AC: 37513AN: 1438376Hom.: 713 Cov.: 26 AF XY: 0.0265 AC XY: 18992AN XY: 716194 show subpopulations
GnomAD4 exome
AF:
AC:
37513
AN:
1438376
Hom.:
Cov.:
26
AF XY:
AC XY:
18992
AN XY:
716194
show subpopulations
African (AFR)
AF:
AC:
98
AN:
32896
American (AMR)
AF:
AC:
1829
AN:
44176
Ashkenazi Jewish (ASJ)
AF:
AC:
227
AN:
25678
East Asian (EAS)
AF:
AC:
3563
AN:
38992
South Asian (SAS)
AF:
AC:
3804
AN:
84880
European-Finnish (FIN)
AF:
AC:
2484
AN:
52204
Middle Eastern (MID)
AF:
AC:
42
AN:
5694
European-Non Finnish (NFE)
AF:
AC:
23907
AN:
1094534
Other (OTH)
AF:
AC:
1559
AN:
59322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1707
3414
5121
6828
8535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0218 AC: 3313AN: 152124Hom.: 64 Cov.: 32 AF XY: 0.0229 AC XY: 1705AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
3313
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
1705
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
162
AN:
41510
American (AMR)
AF:
AC:
410
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
36
AN:
3470
East Asian (EAS)
AF:
AC:
412
AN:
5160
South Asian (SAS)
AF:
AC:
222
AN:
4810
European-Finnish (FIN)
AF:
AC:
498
AN:
10592
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1534
AN:
67986
Other (OTH)
AF:
AC:
39
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
146
291
437
582
728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
143
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.